HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Shaomin Hu Selected Research
Shaomin Hu Research Topics
Disease
4
Neoplasms (Cancer)
01/2021 - 08/2012
3
Infections
07/2015 - 11/2011
2
Hepatocellular Carcinoma (Hepatoma)
01/2020 - 04/2019
2
Schistosomiasis (Bilharziasis)
10/2009 - 10/2008
1
Colorectal Neoplasms (Colorectal Cancer)
01/2021
1
Melanoma (Melanoma, Malignant)
01/2020
1
Adenoma (Adenomas)
04/2019
1
Stomach Neoplasms (Stomach Cancer)
04/2019
1
Focal Nodular Hyperplasia
04/2019
1
Cholangiocarcinoma
04/2019
1
Leukemia
04/2019
1
Lymphoma (Lymphomas)
04/2019
1
Carcinogenesis
04/2019
1
Endometrial Neoplasms (Endometrial Cancer)
01/2018
1
Carcinoma (Carcinomatosis)
01/2018
1
Endometrioid Carcinoma
01/2018
1
Hypersensitivity (Allergy)
09/2014
1
Atopic Dermatitis (Atopic Eczema)
09/2014
1
Psoriasis (Pustulosis Palmaris et Plantaris)
09/2014
1
Inflammation (Inflammations)
04/2012
1
Reinfection
11/2011
Drug/Important Bio-Agent (IBA)
3
Vaccines
IBA
07/2015 - 10/2008
3
Ligands
IBA
09/2014 - 11/2011
2
Immunoglobulin A (IgA)
IBA
07/2015 - 11/2011
2
Chemokine Receptors
IBA
09/2014 - 11/2011
1
Biomarkers (Surrogate Marker)
IBA
01/2021
1
pembrolizumab
IBA
01/2020
1
Ipilimumab
IBA
01/2020
1
Nivolumab
IBA
01/2020
1
Spectrin
IBA
04/2019
1
Protein Isoforms (Isoforms)
IBA
04/2019
1
Estrogen Receptors
IBA
01/2018
1
Antibodies
IBA
01/2018
1
Antigens
IBA
04/2012
1
Proteins (Proteins, Gene)
FDA Link
04/2012
1
Cytokines
IBA
04/2012
1
Chemokines
IBA
04/2012
1
Biological Products
IBA
10/2009
Therapy/Procedure
2
Immunotherapy
01/2021 - 01/2020